Corporate
Imunon's Chief Scientific Officer Retires as Micro-Cap Biotech Cuts Costs to Save Phase 3 Trial
Feb 5
You're signed outSign in or to get full access.
I
Imunon (IMNN)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q2 2025
View earnings summary and analysis
Q1 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Research analysts covering Imunon.